The following article is part of conference coverage from the 2019 American Psychiatric Association Annual Meeting (APA 2019) in San Francisco, CA. Psychiatry Advisor’s staff will be reporting breaking news associated with research conducted by leading experts in psychiatry. Check back for the latest news from APA 2019.
SAN FRANCISCO — Knowledge of pathological imaging findings characteristic of alcohol-related central nervous system disorders may help clinicians reach an accurate early diagnosis, according to research presented at the American Psychiatric Association’s Annual Meeting, held May 18-22, 2019, in San Francisco, California.
A significant proportion of inpatient psychiatric hospitalizations can be linked to alcohol-related diseases. The emerging field of psychoradiology applies medical imaging technology to the analysis of neurophysiology, mental health, and psychiatric conditions. The researchers presented and discussed a number of alcohol-related imaging findings to help clinicians and psychiatrists learn to recognize patterns associated with such pathologies that can be used for reaching diagnoses. General topics discussed related to clinical presentation, normal anatomy, imaging findings, prognosis and treatment, and conclusions. Original images for the following conditions were presented and discussed: atrophy, central pontine myelinolysis, fetal alcohol syndrome, hepatic encephalopathy, Marchiafava Bignami disease, and Wernicke encephalopathy.
“An intuitive understanding of the most common imaging findings associated with various alcohol-related diseases will help direct early imaging evaluation. The psychiatrist’s role as a consultant also necessitates that imaging findings be communicated in the most clinically relevant way to ensure effective early evaluation,” noted the presenters.
For more coverage of APA 2019, click here.
Kansal S, Pothen N, Soloway A, Spaedy A, Anand N, Solhkhah R. Central nervous system disorders attributable to alcohol abuse: an imaging review of recognizable patterns of disease. Poster presented at: The 2019 American Psychiatric Association Annual Meeting; May 18-22, 2019; San Francisco, CA. Abstract 89.